Smith Hayes Advisers’s GSK GSK Stock Holding History

Smith Hayes Advisers’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$579K	Sell	11,414 -75	-0.7%	-$3.73K	0.12%	186
2015 Q4	$579K	Buy	11,489 +555	+5%	+$28.3K	0.12%	184
2015 Q3	$526K	Sell	10,934 -8	-0.1%	-$416	0.11%	180
2015 Q2	$570K	Buy	10,942 +201	+2%	+$11.3K	0.11%	185
2015 Q1	$620K	Buy	10,741 +6,163	+135%	+$353K	0.12%	191
2014 Q4	$245K	Sell	4,578 -373	-8%	-$20.9K	0.05%	268
2014 Q3	$285K	Buy	4,951 +553	+13%	+$33.9K	0.07%	239
2014 Q2	$294K	Buy	4,398 +200	+5%	+$13.5K	0.07%	233
2014 Q1	$280K	Buy	+4,198	New	+$284K	0.07%	233

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Smith Hayes Advisers's GSK Position: Q1 2016 in Review

Smith Hayes Advisers reduced its GSK (GSK) stake by 0.65% in Q1 2016, selling an estimated $3.73K and leaving 11,414 shares worth $579K. The position accounts for 0.12% of the portfolio, ranked #186.

Smith Hayes Advisers first reported a position in GSK in Q1 2014 and has held it in 9 quarters since. The position peaked at $620K in Q1 2015. 726 funds tracked by Wall St. Rank hold GSK as of Q1 2016.

Smith Hayes Advisers held 11,414 shares of GSK worth $579K as of Q1 2016.
Smith Hayes Advisers sold 75 GSK shares in Q1 2016, an estimated $3.73K.
GSK made up 0.12% of Smith Hayes Advisers's portfolio in Q1 2016, its #186 holding.
Smith Hayes Advisers first reported a position in GSK in Q1 2014 and has held it in 9 quarters since.
Smith Hayes Advisers's GSK position peaked at $620K in Q1 2015.
726 funds tracked by Wall St. Rank held GSK as of Q1 2016.

Based on Smith Hayes Advisers's 13F filing for Q1 2016, filed 16 May 2016.